• China has approved 11 new traditional Chinese medicines this year, including Yiling’s depression-resolving drug.
• Yiling Pharmaceutical currently has 13 patent TCMs catering to various diseases.

Yiling Pharmaceutical has recently received approval for marketing its Depression-resolving drug and Restlessness-relieving capsules through the Drug Registration Certificate issued by China's National Medical Products Administration (NMPA). The drug’s full intellectual property rights are owned by the company.

The drug and capsules are an innovative traditional Chinese medicine-(TCM), exclusively developed by Yiling Pharmaceutical, based on clinical practices applicable to mild & moderate depression that include symptoms of moodiness, loss of appetite, dysphoria, dizziness & tinnitus, and insomnia & dreaminess.

The drug underwent a randomized, multicenter, double-simulated, double-blind, and placebo-fluoxetine hydrochloride tablet monitored clinical trial.

The results indicated that as per the reduced values for chief efficacy pointers of the Hamilton Depression Scale-(HAMD-17) scores from the baseline, the test group showed better effectiveness compared to the placebo group, and also not less in comparison to the fluoxetine hydrochloride tablets group.

Moreover, the results also showed improved performance for individual traditional Chinese medicine (TCM) syndromes like mental depression, dizziness & tinnitus, insomnia & dreaminess, restlessness, as well as in Hamilton Anxiety Scale (HAMA) scores.

Notably, China has approved 11 new traditional Chinese medicines this year, which has been considered to be an all-time high in recent years. The two innovative patent TCMs of "Kidney-tonifying and Heart-nourishing Tranquilization Tablets" and "Depression-resolving and Restlessness-relieving Capsules" exclusively developed by Yiling Pharmaceutical has made it to the list.

So far, Yiling Pharmaceutical owns around 13 patent traditional Chinese medicines, covering respiratory diseases, cardiovascular & cerebrovascular diseases, tumors, nervous system diseases, and diabetes, including many more.

According to sources, the Lianhua Qingwen TCM Capsules is now a premium brand for dealing with colds, while Shensong Yangxin Capsules, Tongxinluo Capsules, and Qiliqiangxin Capsules are the main drugs used for treating cardiovascular & cerebrovascular diseases.

Source Credits:

https://www.prnewswire.com/news-releases/yiling-pharmaceuticals-patent-depression-resolving-drug-approved-for-marketing-in-china-301450241.html